While further investigations are necessary to evaluate their protective effect on neuronal damage and subsequent cognitive decline, this study suggests a potential therapeutic benefit of NEP2-secreting hiPSC-ML for the treatment of AD. Here, MMEL1 is linked to Alzheimer disease.